$BIOS BioScrip Inc. Company Overview
BioScrip, Inc. provides pharmacy and home health services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivers access to prescription medications and home health services. Its services are designed to improve clinical outcomes with chronic and acute healthcare conditions. The company operates through two segments: Infusion/Home Health Services and Pharmacy Services. The Infusion/Home Health Services segment consists of its home infusion business combined with the home infusion and home health service businesses. Its infusion services include home infusion therapy, respiratory therapy and durable medical equipment and dispensing and administering of infusion-based drugs, which typically require additional nursing and clinical management services, equipment to administer the correct dosage and patient training designed to improve patient outcomes. This segment's home health services include the provision of skilled nursing and therapy visits, private duty nursing services, rehabilitation services, hospice and medical social services to patients primarily in their home. The Pharmacy Services segment consists of its traditional and specialty pharmacy mail operations, community pharmacies, prescription discount card programs and integrated pharmacy benefit management services. Its services are designed to offer patients and other customers' the delivery of traditional and specialty pharmacy products and services and also includes care management programs customized to each patient's care plan in coordination with the patient's physician. BioScrip was founded in 1996 and is headquartered in Elmsford, NY.
BIOS Last Price: 6.92
Last Updated: November 28, 2013 8:28 PM EST
BIOS Stock Message Board and Forum http://investorshangout.com/search?q=BIOS&...mp;yt0=Go!
BioScrip Inc. BIOS Officers and Executives
Name Age Officer Since Title
Mr. Myron Z. Holubiak 66 2005 Chairman
Mr. Richard M. Smith 53 2009 President, Chief Executive Officer, COO & Director
Mr. Hai V. Tran 43 2011 Chief Financial Officer & Senior Vice President
Mr. Rick Goldsby - - Chief Information Officer
Mr. Daniel Colucci 48 2001 VP-Pharmacy Benefit Management Services
BioScrip, Inc.
100 Clearbrook Road
Elmsford, New York 10523
Phone
1 9144601600
Industry
Health Care Providers
Sector
Health Care
Fiscal Year-end
12/2013
View SEC Filings Below
Revenue
$662.64M
Net Income
$-8.34M
Employees
2,198
Annual Report Below for BIOS
BioScrip Inc. BIOS Recent Headlines
MarketWatch News on BIOS
BioScrip to buy HomeChoice for $70 million 7:18 a.m. Dec. 13, 2012 - MarketWatch.com
In focus: Short-term correction is almost over 10:57 p.m. Oct. 3, 2012 - Lawrence G. McMillan
BioScrip shares more than double after outlook 6:16 a.m. Aug. 9, 2012 - Greg Morcroft
Stocks to watch Friday: TI, Molycorp, Heckmann 6:51 a.m. March 9, 2012 - MarketWatch
Walgreen to buy BioScrip units for $225 million 1:47 p.m. Feb. 2, 2012 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 4:04 p.m. Nov. 2, 2010 - Robert Daniel
Friday's biggest gaining and declining stocks 4:01 p.m. July 30, 2010 - MarketWatch
Updates, advisories and surprises 3:01 p.m. July 30, 2010 - MarketWatch
BioScrip falls; revenue seen lower end of outlook 10:03 a.m. July 30, 2010 - Robert Daniel
BioScrip to buy Critical Homecare for $343.2 mln 6:17 a.m. Jan. 25, 2010 - Simon Kennedy
BioScrip paying aggregate of $343.2M 6:04 a.m. Jan. 25, 2010 - Simon Kennedy
BioScrip to acquire Critical Homecare Solutions 6:03 a.m. Jan. 25, 2010 - Simon Kennedy
Despite volatility, S&P holds surprisingly near record highs 11:33 a.m. Dec. 11, 2007 - Michael Ashbaugh
Can the Fed fuel further gains? 9:51 a.m. Dec. 11, 2007 - Michael Ashbaugh
S&P, Nasdaq place distance atop major resistance 8:47 a.m. Aug. 27, 2007 - Michael Ashbaugh
Nasdaq, Dow lift within view of new highs 9:30 a.m. Dec. 6, 2006 - Michael Ashbaugh
Sector rotation, not technical breakdown 11:04 a.m. Dec. 1, 2006 - MarketWatch
Bioscrip shares set 52-week low of $3.17 12:49 p.m. Sept. 13, 2006 - Michael Baron
Highlights of rising and falling U.S. stocks 6:41 p.m. June 1, 2006 - MarketWatch
BioScrip shares down on news CFO Keane to leave on June 9 12:15 p.m. June 1, 2006 - Michael Baron
Market Wrap For November 27: Markets Inch Higher Before Pausing For Thanksgiving 4:01 p.m. Nov. 27, 2013 - benzinga.com
3 Stocks Improving Performance Of The Health Services Industry 12:05 p.m. Nov. 27, 2013 - TheStreet.com
Coram deal strengthens CVS Caremark against Walgreens 11:00 a.m. Nov. 27, 2013 - Seeking Alpha
Top Performing Industries For November 27, 2013 9:19 a.m. Nov. 27, 2013 - benzinga.com
First Week Of BIOS July 2014 Options Trading 12:43 p.m. Nov. 19, 2013 - TheStreet.com
10-Q: BIOSCRIP, INC. 4:14 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
BioScrip Earnings In Line, Revs Beat - Analyst Blog 9:20 a.m. Nov. 12, 2013 - Zacks.com
BIOS, INWK, LAYN - Mario Gabelli Update 9:25 a.m. Nov. 8, 2013 - GuruFocus.com
BioScrip Management Discusses Q3 2013 Results - Earnings Call Transcript 1:20 p.m. Nov. 7, 2013 - Seeking Alpha
BIOS Falls To Levels Below Book Value 12:58 p.m. Nov. 7, 2013 - TheStreet.com
BioScrip Becomes Oversold (BIOS) 12:38 p.m. Nov. 7, 2013 - TheStreet.com
BioScrip Stock Sees Short Interest Make 28% Move 3:47 p.m. Oct. 25, 2013 - TheStreet.com
Stocks Hitting 52-Week Lows 9:16 a.m. Oct. 25, 2013 - benzinga.com
Interesting BIOS Put And Call Options For December 21st 10:42 a.m. Oct. 24, 2013 - TheStreet.com
Gentiva Closes Harden Buyout - Analyst Blog 3:30 p.m. Oct. 21, 2013 - Zacks.com
The BioScrip Inc. (BIOS) Moving Average Crossover Spotted - Tale of the Tape 3:54 a.m. Oct. 2, 2013 - Zacks.com
Zacks #5 Rank Additions for Monday - Tale of the Tape 9:30 a.m. Sept. 30, 2013 - Zacks.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
First Week Of November 16th Options Trading For BioScrip (BIOS) 1:56 p.m. Sept. 26, 2013 - TheStreet.com
Trade-Ideas: BioScrip (BIOS) Is Today's "Perilous Reversal" Stock 10:45 a.m. Sept. 26, 2013 - TheStreet.com
Press Releases on BIOS
BIOSCRIP 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against BioScrip Inc. - BIOS 10:00 p.m. Nov. 26, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against BioScrip, Inc. 4:14 p.m. Nov. 22, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against BioScrip, Inc. and Certain Officers - BIOS 8:00 a.m. Nov. 22, 2013 - PR Newswire
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 4:40 p.m. Nov. 18, 2013 - BusinessWire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of BioScrip, Inc. of Upcoming Deadline 10:51 a.m. Nov. 15, 2013 - BusinessWire
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 4:15 p.m. Nov. 12, 2013 - BusinessWire
BioScrip Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 3:46 p.m. Nov. 11, 2013 - BusinessWire
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares 8:00 a.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in BioScrip, Inc. of Class Action Lawsuit and Upcoming Deadline -- BIOS 7:30 a.m. Nov. 11, 2013 - GlobeNewswire
TrendingWallStreet.com Issues Market Analysis on AA, SGLB, FMCC, and BIOS 12:20 a.m. Nov. 8, 2013 - ACCESSWIRE
BIOSCRIP SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioScrip Inc. 10:00 p.m. Nov. 7, 2013 - BusinessWire
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
BioScrip Reports Third Quarter 2013 Financial Results 5:00 p.m. Nov. 6, 2013 - PR Newswire
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 -- BIOS 6:12 p.m. Oct. 21, 2013 - GlobeNewswire
BioScrip To Host Third Quarter 2013 Earnings Call 4:30 p.m. Oct. 21, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in BioScrip, Inc. of Class Action Lawsuit and Upcoming Deadline -- BIOS 7:00 a.m. Oct. 14, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In BioScrip, Inc. To Contact The Firm 8:30 p.m. Oct. 11, 2013 - PR Newswire
Lifshitz Law Firm Announces Investigation of Active Network, BioScrip, Inc., Edgen Group Inc., Flow International Corporation and Zoltek Companies, Inc. 2:14 p.m. Oct. 9, 2013 - PR Newswire
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against BioScrip, Inc. -- BIOS 7:00 p.m. Oct. 7, 2013 - GlobeNewswire
Lawsuit on Behalf of Investors in BioScrip Inc (BIOS) Announced by Shareholders Foundation 9:35 a.m. Oct. 7, 2013 - GlobeNewswire
Valuation
P/E Current
6.02
P/E Ratio (with extraordinary items)
-10.70
P/E Ratio (without extraordinary items)
9.37
Price to Sales Ratio
0.91
Price to Book Ratio
2.09
Price to Cash Flow Ratio
22.53
Enterprise Value to EBITDA
16.30
Enterprise Value to Sales
0.73
Total Debt to Enterprise Value
0.29
Efficiency
Revenue/Employee
0.30
Income Per Employee
0.00
Receivables Turnover
3.74
Total Asset Turnover
1.00
Liquidity
Current Ratio
2.17
Quick Ratio
1.86
Cash Ratio
0.57
Profitability
Gross Margin
33.35
Operating Margin
3.39
Pretax Margin
-1.93
Net Margin
-1.26
Return on Assets
-1.26
Return on Equity
-3.28
Return on Total Capital
-1.62
Return on Invested Capital
-1.73
Capital Structure
Total Debt to Total Equity
77.15
Total Debt to Total Capital
43.55
Total Debt to Total Assets
35.24
Long-Term Debt to Equity
76.83
Long-Term Debt to Total Capital
43.37
BioScrip Inc. BIOS Financials
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 1.4B 1.33B 1.64B 1.82B 662.64M
Cost of Goods Sold (COGS) incl. D&A 1.26B 1.17B 1.38B 1.51B 441.63M
COGS excluding D&A 1.26B 1.17B 1.37B 1.5B 429.16M
Depreciation & Amortization Expense 6.39M 5.03M 12.33M 15.88M 12.47M
Depreciation 4.46M 5.03M 8.56M 10.69M 8.51M
Amortization of Intangibles 1.94M - 3.77M 5.19M 3.96M
Gross Income 140.23M 157.82M 256.64M 307.11M 221M
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 129.87M 142.36M 226.34M 255.93M 198.53M
Research & Development 0 0 0 0 0
Other SG&A 129.87M 142.36M 226.34M 255.93M 198.53M
Other Operating Expense 0 0 0 0 0
Unusual Expense 93.88M 0 24.07M 13.69M 9.19M
EBIT after Unusual Expense (93.88M) 0 (24.07M) (13.69M) (9.19M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 0 0 - 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 2.71M 1.92M 27.65M 28.31M 26.07M
Gross Interest Expense 2.71M 1.92M 27.65M 28.31M 26.07M
Interest Capitalized 0 0 0 0 0
Pretax Income (86.23M) 13.55M (21.41M) 9.2M (12.78M)
Income Tax (12.2M) (40.55M) 47.73M 1.32M (4.44M)
Income Tax - Current Domestic 25,000 (36,000) 391,000 168,000 (4.44M)
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic (12.22M) (40.52M) 47.34M 1.16M (4,000)
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (74.03M) 54.1M (69.14M) 7.87M (8.34M)
Minority Interest Expense 0 0 0 0 0
Net Income (74.03M) 54.1M (69.14M) 7.87M (8.34M)
Extraordinaries & Discontinued Operations 0 0 0 0 73.05M
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 73.05M
Net Income After Extraordinaries (74.03M) 54.1M (69.14M) 7.87M 64.71M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (74.03M) 54.1M (69.14M) 7.87M (8.34M)
EPS (Basic) (1.93) 1.39 (1.37) 0.14 1.15
Basic Shares Outstanding 38.42M 38.99M 50.37M 54.51M 56.24M
EPS (Diluted) (1.93) 1.36 (1.37) 0.14 1.15
Diluted Shares Outstanding 38.42M 39.74M 50.37M 55.15M 56.24M
EBITDA 16.76M 20.5M 42.63M 67.06M 34.95M
BioScrip Inc. BIOS Filings
SEC Filings for BioScrip Inc.
Filing Date Document Date Type Category Amended
11/27/2013 11/25/2013 8-K Special Events
11/12/2013 09/30/2013 10-Q Quarterly Reports
11/08/2013 08/23/2013 8-K/A Special Events *
11/08/2013 N/A SC 13G Institutional Ownership
11/06/2013 11/06/2013 8-K Special Events
09/23/2013 09/23/2013 8-K Special Events
09/23/2013 09/23/2013 8-K Special Events
08/27/2013 N/A SC 13D/A N/A *
08/27/2013 08/23/2013 8-K Special Events
08/19/2013 08/13/2013 8-K Special Events
08/15/2013 08/14/2013 8-K Special Events
08/14/2013 08/13/2013 8-K Special Events
08/08/2013 06/30/2013 10-Q Quarterly Reports
08/07/2013 08/07/2013 8-K Special Events
08/01/2013 07/31/2013 8-K Special Events
07/19/2013 07/19/2013 8-K Special Events
07/09/2013 07/09/2013 8-K Special Events
06/18/2013 06/16/2013 8-K Special Events
06/17/2013 06/17/2013 8-K Special Events
06/03/2013 06/03/2013 8-K Special Events
SEC Filings provided by EDGAR Online, Inc.
BIOS BioScrip Inc. Research Links
Stock Message Board http://investorshangout.com/search?q=BIOS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIOS/quote
Stock Chart http://www.otcmarkets.com/stock/BIOS/chart
Company Info http://www.otcmarkets.com/stock/BIOS/company-info
Recent News http://www.otcmarkets.com/stock/BIOS/news
Financials http://www.otcmarkets.com/stock/BIOS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIOS/filings
Short Sales http://www.otcmarkets.com/stock/BIOS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIOS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIOS/research
Summary http://finance.yahoo.com/q?s=BIOS
Historical Prices http://finance.yahoo.com/q/hp?s=BIOS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIOS
Basic Chart http://finance.yahoo.com/q/bc?s=BIOS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIOS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIOS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIOS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIOS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIOS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIOS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIOS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIOS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIOS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIOS
Balance Sheet http://finance.yahoo.com/q/bs?s=BIOS
Cash Flow http://finance.yahoo.com/q/cf?s=BIOS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIOS
Market Watch http://www.marketwatch.com/investing/stock/BIOS
Bloomberg http://www.bloomberg.com/quote/BIOS:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIOS
Bussinessweek http://investing.businessweek.com/research/st...icker=BIOS
Barchart http://www.barchart.com/quotes/stocks/BIOS
OTC Short Report http://otcshortreport.com/index.php?index=BIOS
Investopedia http://www.investopedia.com/markets/stocks/BIOS/?wa=0
List of all stock message boards and tickers for NYSE New York Stock Exchange http://investorshangout.com/board?categoryid=NYSE
BioScrip, Inc. provides pharmacy and home health services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivers access to prescription medications and home health services. Its services are designed to improve clinical outcomes with chronic and acute healthcare conditions. The company operates through two segments: Infusion/Home Health Services and Pharmacy Services. The Infusion/Home Health Services segment consists of its home infusion business combined with the home infusion and home health service businesses. Its infusion services include home infusion therapy, respiratory therapy and durable medical equipment and dispensing and administering of infusion-based drugs, which typically require additional nursing and clinical management services, equipment to administer the correct dosage and patient training designed to improve patient outcomes. This segment's home health services include the provision of skilled nursing and therapy visits, private duty nursing services, rehabilitation services, hospice and medical social services to patients primarily in their home. The Pharmacy Services segment consists of its traditional and specialty pharmacy mail operations, community pharmacies, prescription discount card programs and integrated pharmacy benefit management services. Its services are designed to offer patients and other customers' the delivery of traditional and specialty pharmacy products and services and also includes care management programs customized to each patient's care plan in coordination with the patient's physician. BioScrip was founded in 1996 and is headquartered in Elmsford, NY.
BIOS Last Price: 6.92
Last Updated: November 28, 2013 8:28 PM EST
BIOS Stock Message Board and Forum http://investorshangout.com/search?q=BIOS&...mp;yt0=Go!
BioScrip Inc. BIOS Officers and Executives
Name Age Officer Since Title
Mr. Myron Z. Holubiak 66 2005 Chairman
Mr. Richard M. Smith 53 2009 President, Chief Executive Officer, COO & Director
Mr. Hai V. Tran 43 2011 Chief Financial Officer & Senior Vice President
Mr. Rick Goldsby - - Chief Information Officer
Mr. Daniel Colucci 48 2001 VP-Pharmacy Benefit Management Services
BioScrip, Inc.
100 Clearbrook Road
Elmsford, New York 10523
Phone
1 9144601600
Industry
Health Care Providers
Sector
Health Care
Fiscal Year-end
12/2013
View SEC Filings Below
Revenue
$662.64M
Net Income
$-8.34M
Employees
2,198
Annual Report Below for BIOS
BioScrip Inc. BIOS Recent Headlines
MarketWatch News on BIOS
BioScrip to buy HomeChoice for $70 million 7:18 a.m. Dec. 13, 2012 - MarketWatch.com
In focus: Short-term correction is almost over 10:57 p.m. Oct. 3, 2012 - Lawrence G. McMillan
BioScrip shares more than double after outlook 6:16 a.m. Aug. 9, 2012 - Greg Morcroft
Stocks to watch Friday: TI, Molycorp, Heckmann 6:51 a.m. March 9, 2012 - MarketWatch
Walgreen to buy BioScrip units for $225 million 1:47 p.m. Feb. 2, 2012 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 4:04 p.m. Nov. 2, 2010 - Robert Daniel
Friday's biggest gaining and declining stocks 4:01 p.m. July 30, 2010 - MarketWatch
Updates, advisories and surprises 3:01 p.m. July 30, 2010 - MarketWatch
BioScrip falls; revenue seen lower end of outlook 10:03 a.m. July 30, 2010 - Robert Daniel
BioScrip to buy Critical Homecare for $343.2 mln 6:17 a.m. Jan. 25, 2010 - Simon Kennedy
BioScrip paying aggregate of $343.2M 6:04 a.m. Jan. 25, 2010 - Simon Kennedy
BioScrip to acquire Critical Homecare Solutions 6:03 a.m. Jan. 25, 2010 - Simon Kennedy
Despite volatility, S&P holds surprisingly near record highs 11:33 a.m. Dec. 11, 2007 - Michael Ashbaugh
Can the Fed fuel further gains? 9:51 a.m. Dec. 11, 2007 - Michael Ashbaugh
S&P, Nasdaq place distance atop major resistance 8:47 a.m. Aug. 27, 2007 - Michael Ashbaugh
Nasdaq, Dow lift within view of new highs 9:30 a.m. Dec. 6, 2006 - Michael Ashbaugh
Sector rotation, not technical breakdown 11:04 a.m. Dec. 1, 2006 - MarketWatch
Bioscrip shares set 52-week low of $3.17 12:49 p.m. Sept. 13, 2006 - Michael Baron
Highlights of rising and falling U.S. stocks 6:41 p.m. June 1, 2006 - MarketWatch
BioScrip shares down on news CFO Keane to leave on June 9 12:15 p.m. June 1, 2006 - Michael Baron
Market Wrap For November 27: Markets Inch Higher Before Pausing For Thanksgiving 4:01 p.m. Nov. 27, 2013 - benzinga.com
3 Stocks Improving Performance Of The Health Services Industry 12:05 p.m. Nov. 27, 2013 - TheStreet.com
Coram deal strengthens CVS Caremark against Walgreens 11:00 a.m. Nov. 27, 2013 - Seeking Alpha
Top Performing Industries For November 27, 2013 9:19 a.m. Nov. 27, 2013 - benzinga.com
First Week Of BIOS July 2014 Options Trading 12:43 p.m. Nov. 19, 2013 - TheStreet.com
10-Q: BIOSCRIP, INC. 4:14 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
BioScrip Earnings In Line, Revs Beat - Analyst Blog 9:20 a.m. Nov. 12, 2013 - Zacks.com
BIOS, INWK, LAYN - Mario Gabelli Update 9:25 a.m. Nov. 8, 2013 - GuruFocus.com
BioScrip Management Discusses Q3 2013 Results - Earnings Call Transcript 1:20 p.m. Nov. 7, 2013 - Seeking Alpha
BIOS Falls To Levels Below Book Value 12:58 p.m. Nov. 7, 2013 - TheStreet.com
BioScrip Becomes Oversold (BIOS) 12:38 p.m. Nov. 7, 2013 - TheStreet.com
BioScrip Stock Sees Short Interest Make 28% Move 3:47 p.m. Oct. 25, 2013 - TheStreet.com
Stocks Hitting 52-Week Lows 9:16 a.m. Oct. 25, 2013 - benzinga.com
Interesting BIOS Put And Call Options For December 21st 10:42 a.m. Oct. 24, 2013 - TheStreet.com
Gentiva Closes Harden Buyout - Analyst Blog 3:30 p.m. Oct. 21, 2013 - Zacks.com
The BioScrip Inc. (BIOS) Moving Average Crossover Spotted - Tale of the Tape 3:54 a.m. Oct. 2, 2013 - Zacks.com
Zacks #5 Rank Additions for Monday - Tale of the Tape 9:30 a.m. Sept. 30, 2013 - Zacks.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
First Week Of November 16th Options Trading For BioScrip (BIOS) 1:56 p.m. Sept. 26, 2013 - TheStreet.com
Trade-Ideas: BioScrip (BIOS) Is Today's "Perilous Reversal" Stock 10:45 a.m. Sept. 26, 2013 - TheStreet.com
Press Releases on BIOS
BIOSCRIP 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against BioScrip Inc. - BIOS 10:00 p.m. Nov. 26, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against BioScrip, Inc. 4:14 p.m. Nov. 22, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against BioScrip, Inc. and Certain Officers - BIOS 8:00 a.m. Nov. 22, 2013 - PR Newswire
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 4:40 p.m. Nov. 18, 2013 - BusinessWire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of BioScrip, Inc. of Upcoming Deadline 10:51 a.m. Nov. 15, 2013 - BusinessWire
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 4:15 p.m. Nov. 12, 2013 - BusinessWire
BioScrip Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 3:46 p.m. Nov. 11, 2013 - BusinessWire
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares 8:00 a.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in BioScrip, Inc. of Class Action Lawsuit and Upcoming Deadline -- BIOS 7:30 a.m. Nov. 11, 2013 - GlobeNewswire
TrendingWallStreet.com Issues Market Analysis on AA, SGLB, FMCC, and BIOS 12:20 a.m. Nov. 8, 2013 - ACCESSWIRE
BIOSCRIP SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioScrip Inc. 10:00 p.m. Nov. 7, 2013 - BusinessWire
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
BioScrip Reports Third Quarter 2013 Financial Results 5:00 p.m. Nov. 6, 2013 - PR Newswire
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 -- BIOS 6:12 p.m. Oct. 21, 2013 - GlobeNewswire
BioScrip To Host Third Quarter 2013 Earnings Call 4:30 p.m. Oct. 21, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in BioScrip, Inc. of Class Action Lawsuit and Upcoming Deadline -- BIOS 7:00 a.m. Oct. 14, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In BioScrip, Inc. To Contact The Firm 8:30 p.m. Oct. 11, 2013 - PR Newswire
Lifshitz Law Firm Announces Investigation of Active Network, BioScrip, Inc., Edgen Group Inc., Flow International Corporation and Zoltek Companies, Inc. 2:14 p.m. Oct. 9, 2013 - PR Newswire
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against BioScrip, Inc. -- BIOS 7:00 p.m. Oct. 7, 2013 - GlobeNewswire
Lawsuit on Behalf of Investors in BioScrip Inc (BIOS) Announced by Shareholders Foundation 9:35 a.m. Oct. 7, 2013 - GlobeNewswire
Valuation
P/E Current
6.02
P/E Ratio (with extraordinary items)
-10.70
P/E Ratio (without extraordinary items)
9.37
Price to Sales Ratio
0.91
Price to Book Ratio
2.09
Price to Cash Flow Ratio
22.53
Enterprise Value to EBITDA
16.30
Enterprise Value to Sales
0.73
Total Debt to Enterprise Value
0.29
Efficiency
Revenue/Employee
0.30
Income Per Employee
0.00
Receivables Turnover
3.74
Total Asset Turnover
1.00
Liquidity
Current Ratio
2.17
Quick Ratio
1.86
Cash Ratio
0.57
Profitability
Gross Margin
33.35
Operating Margin
3.39
Pretax Margin
-1.93
Net Margin
-1.26
Return on Assets
-1.26
Return on Equity
-3.28
Return on Total Capital
-1.62
Return on Invested Capital
-1.73
Capital Structure
Total Debt to Total Equity
77.15
Total Debt to Total Capital
43.55
Total Debt to Total Assets
35.24
Long-Term Debt to Equity
76.83
Long-Term Debt to Total Capital
43.37
BioScrip Inc. BIOS Financials
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 1.4B 1.33B 1.64B 1.82B 662.64M
Cost of Goods Sold (COGS) incl. D&A 1.26B 1.17B 1.38B 1.51B 441.63M
COGS excluding D&A 1.26B 1.17B 1.37B 1.5B 429.16M
Depreciation & Amortization Expense 6.39M 5.03M 12.33M 15.88M 12.47M
Depreciation 4.46M 5.03M 8.56M 10.69M 8.51M
Amortization of Intangibles 1.94M - 3.77M 5.19M 3.96M
Gross Income 140.23M 157.82M 256.64M 307.11M 221M
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 129.87M 142.36M 226.34M 255.93M 198.53M
Research & Development 0 0 0 0 0
Other SG&A 129.87M 142.36M 226.34M 255.93M 198.53M
Other Operating Expense 0 0 0 0 0
Unusual Expense 93.88M 0 24.07M 13.69M 9.19M
EBIT after Unusual Expense (93.88M) 0 (24.07M) (13.69M) (9.19M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 0 0 - 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 2.71M 1.92M 27.65M 28.31M 26.07M
Gross Interest Expense 2.71M 1.92M 27.65M 28.31M 26.07M
Interest Capitalized 0 0 0 0 0
Pretax Income (86.23M) 13.55M (21.41M) 9.2M (12.78M)
Income Tax (12.2M) (40.55M) 47.73M 1.32M (4.44M)
Income Tax - Current Domestic 25,000 (36,000) 391,000 168,000 (4.44M)
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic (12.22M) (40.52M) 47.34M 1.16M (4,000)
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (74.03M) 54.1M (69.14M) 7.87M (8.34M)
Minority Interest Expense 0 0 0 0 0
Net Income (74.03M) 54.1M (69.14M) 7.87M (8.34M)
Extraordinaries & Discontinued Operations 0 0 0 0 73.05M
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 73.05M
Net Income After Extraordinaries (74.03M) 54.1M (69.14M) 7.87M 64.71M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (74.03M) 54.1M (69.14M) 7.87M (8.34M)
EPS (Basic) (1.93) 1.39 (1.37) 0.14 1.15
Basic Shares Outstanding 38.42M 38.99M 50.37M 54.51M 56.24M
EPS (Diluted) (1.93) 1.36 (1.37) 0.14 1.15
Diluted Shares Outstanding 38.42M 39.74M 50.37M 55.15M 56.24M
EBITDA 16.76M 20.5M 42.63M 67.06M 34.95M
BioScrip Inc. BIOS Filings
SEC Filings for BioScrip Inc.
Filing Date Document Date Type Category Amended
11/27/2013 11/25/2013 8-K Special Events
11/12/2013 09/30/2013 10-Q Quarterly Reports
11/08/2013 08/23/2013 8-K/A Special Events *
11/08/2013 N/A SC 13G Institutional Ownership
11/06/2013 11/06/2013 8-K Special Events
09/23/2013 09/23/2013 8-K Special Events
09/23/2013 09/23/2013 8-K Special Events
08/27/2013 N/A SC 13D/A N/A *
08/27/2013 08/23/2013 8-K Special Events
08/19/2013 08/13/2013 8-K Special Events
08/15/2013 08/14/2013 8-K Special Events
08/14/2013 08/13/2013 8-K Special Events
08/08/2013 06/30/2013 10-Q Quarterly Reports
08/07/2013 08/07/2013 8-K Special Events
08/01/2013 07/31/2013 8-K Special Events
07/19/2013 07/19/2013 8-K Special Events
07/09/2013 07/09/2013 8-K Special Events
06/18/2013 06/16/2013 8-K Special Events
06/17/2013 06/17/2013 8-K Special Events
06/03/2013 06/03/2013 8-K Special Events
SEC Filings provided by EDGAR Online, Inc.
BIOS BioScrip Inc. Research Links
Stock Message Board http://investorshangout.com/search?q=BIOS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIOS/quote
Stock Chart http://www.otcmarkets.com/stock/BIOS/chart
Company Info http://www.otcmarkets.com/stock/BIOS/company-info
Recent News http://www.otcmarkets.com/stock/BIOS/news
Financials http://www.otcmarkets.com/stock/BIOS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIOS/filings
Short Sales http://www.otcmarkets.com/stock/BIOS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIOS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIOS/research
Summary http://finance.yahoo.com/q?s=BIOS
Historical Prices http://finance.yahoo.com/q/hp?s=BIOS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIOS
Basic Chart http://finance.yahoo.com/q/bc?s=BIOS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIOS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIOS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIOS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIOS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIOS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIOS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIOS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIOS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIOS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIOS
Balance Sheet http://finance.yahoo.com/q/bs?s=BIOS
Cash Flow http://finance.yahoo.com/q/cf?s=BIOS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIOS
Market Watch http://www.marketwatch.com/investing/stock/BIOS
Bloomberg http://www.bloomberg.com/quote/BIOS:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIOS
Bussinessweek http://investing.businessweek.com/research/st...icker=BIOS
Barchart http://www.barchart.com/quotes/stocks/BIOS
OTC Short Report http://otcshortreport.com/index.php?index=BIOS
Investopedia http://www.investopedia.com/markets/stocks/BIOS/?wa=0
List of all stock message boards and tickers for NYSE New York Stock Exchange http://investorshangout.com/board?categoryid=NYSE
